Vaxcyte’s 24-Valent Pneumococcal Vaccine Shows Best-In-Class Potential

Small Biotech Hopes To Compete In Big Pharma-Dominated Market

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.